{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:33:56Z","timestamp":1793144036454,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["KWF VU 2009\u20134522"],"award-info":[{"award-number":["KWF VU 2009\u20134522"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["KWF VU 2014\u20137238"],"award-info":[{"award-number":["KWF VU 2014\u20137238"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FP7","award":["CoheaHr-Health-F3-2013-603019"],"award-info":[{"award-number":["CoheaHr-Health-F3-2013-603019"]}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["2012-AdG"],"award-info":[{"award-number":["2012-AdG"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["322986"],"award-info":[{"award-number":["322986"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ygyno.2016.02.012","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T12:05:14Z","timestamp":1457006714000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Validation of the FAM19A4 \/ mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women"],"prefix":"10.1016","volume":"141","clinical-trial-number":[{"clinical-trial-number":"ntr1851","registry":"10.18810\/dutch-trial-register"},{"clinical-trial-number":"ntr2606","registry":"10.18810\/dutch-trial-register"},{"clinical-trial-number":"ntr3350","registry":"10.18810\/dutch-trial-register"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-2295","authenticated-orcid":false,"given":"Lise M.A.","family":"De Strooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola M.J.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertus T.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena M.E.","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert J.","family":"van Kemenade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remko P.","family":"Bosgraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud L.M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske D.M.","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.F.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle A.M.","family":"Heideman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.02.012_bb0005","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/ijc.22114","article-title":"Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands","volume":"119","author":"Bos","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0015","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ijc.22484","article-title":"Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs","volume":"120","author":"Bais","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0020","doi-asserted-by":"crossref","first-page":"c1040","DOI":"10.1136\/bmj.c1040","article-title":"HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study","volume":"340","author":"G\u00f6k","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0025","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.ejca.2011.11.022","article-title":"Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders","volume":"48","author":"G\u00f6k","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0030","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1007\/BF03405681","article-title":"Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis","volume":"104","author":"Racey","year":"2013","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0035","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ijc.26128","article-title":"Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program","volume":"130","author":"G\u00f6k","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.bjc.6606040","article-title":"The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)","volume":"104","author":"Giorgi Rossi","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0045","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(11)61522-5","article-title":"Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial","volume":"378","author":"Lazcano-Ponce","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0050","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ijc.27790","article-title":"High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening","volume":"132","author":"Snijders","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0055","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/bjc.2011.277","article-title":"Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer","volume":"105","author":"Gyllensten","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0060","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1128\/JCM.01506-12","article-title":"Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women","volume":"50","author":"van Baars","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/sti.2004.011858","article-title":"Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis","volume":"81","author":"Ogilvie","year":"2005","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0075","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0080","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0085","doi-asserted-by":"crossref","first-page":"184.e1","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen positive women? A POBASCAM Trial sub study","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0095","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2010.11.013","article-title":"HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review","volume":"120","author":"Burger","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcv.2015.04.004","article-title":"Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women","volume":"67","author":"Luttmer","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0105","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/ijc.28790","article-title":"A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes","volume":"135","author":"Brentnall","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0115","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/ijc.26326","article-title":"A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients","volume":"130","author":"Eijsink","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0120","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/bjc.2014.34","article-title":"Triaging borderline\/mild dyskaryotic Pap cytology with p16\/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study","volume":"110","author":"Uijterwaal","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1470-2045(12)70529-6","article-title":"Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial","volume":"14","author":"Carozzi","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0130","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2009.090122","article-title":"Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears","volume":"175","author":"Andersson","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000438719","article-title":"Clinical role of the detection of human telomerase RNA component gene amplification by fluorescence in situ hybridization on liquid-based cervical samples: comparison with human papillomavirus-DNA testing and histopathology","volume":"59","author":"Zappacosta","year":"2015","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0145","first-page":"266","article-title":"Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus","volume":"102","author":"Garcia","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2014.08.003","article-title":"Methylation marker analysis and HPV16\/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer","volume":"135","author":"Verhoef","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0160","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/bjc.2014.392","article-title":"DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women","volume":"111","author":"Boers","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2010.10.029","article-title":"Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study","volume":"120","author":"Eijsink","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.4210","article-title":"Methylation-specific digital karyotyping of HPV16E6E7 expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis","volume":"231","author":"Steenbergen","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0175","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1940-6207.CAPR-14-0237","article-title":"Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2\/3 lesions","volume":"7","author":"De Strooper","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1476-4598-9-167","article-title":"Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer","volume":"9","author":"Wilting","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0185","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","author":"Bierkens","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0190","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jclinpath-2014-202616","article-title":"CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer","volume":"67","author":"De Strooper","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0195","article-title":"Rijkstinstituut voor Volksgezondheid en Milieu","author":"van der Veen","year":"2013","journal-title":"Uitvoeringstoets wijziging bevolkingsonderzoek baarmoederhalskanker"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0200","article-title":"National cervical screening program renewal: executive summary","author":"Medical service advisory committee","year":"2013","journal-title":"Report November 2013. MSAC Application No. 1276"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0205","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ijc.28723","article-title":"Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy","volume":"135","author":"Hesselink","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0210","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ijc.29026","article-title":"Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening","volume":"136","author":"Bosgraaf","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6874-13-21","article-title":"A second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA results","volume":"13","author":"Verhoef","year":"2013","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0220","series-title":"Premalignant and Malignant Squamous Lesions of the Cervix","author":"Anderson","year":"2013"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0225","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jcp.2003.011841","article-title":"The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996","volume":"57","author":"Bulk","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0230","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2016.02.012_bb0235","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-10-2548","article-title":"Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women","volume":"17","author":"Hesselink","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0240","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.35.3.791-795.1997","article-title":"A general primer GP5+\/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings","volume":"35","author":"Jacobs","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0245","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/JCM.44.2.504-512.2006","article-title":"Bead-based multiplex genotyping of human papillomaviruses bead-based multiplex genotyping of human papillomaviruses","volume":"44","author":"Schmitt","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jmv.2015","article-title":"Detection of high-risk HPV types by the hybrid capture 2 test","volume":"65","author":"Terry","year":"2001","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0255","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JCM.36.10.3020-3027.1998","article-title":"Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. \u2014 PubMed \u2014 NCBI","volume":"10","author":"Gravitt","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0260","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.2367","article-title":"Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC","volume":"1","author":"Overmeer","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2598","article-title":"Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis","volume":"219","author":"Overmeer","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0270","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2008.10.012","article-title":"Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science","volume":"112","author":"Wentzensen","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.02.012_bb0280","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/IGC.0000000000000155","article-title":"PAX1 methylation as a potential biomarker for cervical cancer screening","volume":"24","author":"Kan","year":"2014","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T15:20:01Z","timestamp":1718378401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816300361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0090825816300361"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.02.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the FAM19A4\/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}